Mount Logan Capital Inc. Common Stock (MLCI)
Valuation Overview•Is Mount Logan Capital Inc. Common Stock Overvalued or Undervalued?
The market is pricing the stock in line with historical averages, assuming steady-state growth.
Moderate quality score of 50/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Average quality business weighed down by significant solvency concerns.
Wall Street sentiment is generally neutral alongside robust expected earnings growth. This outlook is strongly supported by highly attractive capital returns, driven by a balanced mix of reliable dividends and share buybacks.
MLCI demonstrates strong business quality with robust profitability and healthy margins. This is paired with a moderately leveraged but stable balance sheet.
The company maintains stable top-line performance paired with stable bottom-line earnings.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $2.3M | -106.3% | — | — | — | |
| EBITDA | -$20.0M | — | — | — | — | |
| Net Income | -$6.0M | -1188.7% | — | — | — | |
| EPS (Diluted) | $-0.51 | -3640.0% | — | — | — | |
| Free Cash Flow | -$24.4M | -179.8% | — | — | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | — | 177.6% | 141.7% | 141.7% |
| Operating Margin | — | 246.1% | 181.0% | 181.0% |
| Net Margin | — | 161.7% | 142.2% | 142.2% |
| FCF Margin | — | 80.0% | 34.3% | 34.3% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q1'26Latest | $-0.01 | $-4.15 | -41400.0% | ||
| Q4'25 | $-0.01 | $-1.64 | -16300.0% | ||
| Q3'25 | $0.09 | $-0.12 | -230.6% |
Total return is -38.8% (1Y), lagging the benchmark by -63.8%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -65.5% | -74.8% | — |
| 1Y | -38.8% | -63.8% | +1.9% |
| 3YCAGR | -15.1% | -34.6% | +1.9% |
| 5YCAGR | -9.4% | -21.8% | +1.9% |
| 10YCAGR | -4.8% | -18.4% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about MLCI (MLCI) valuation, health, and returns.
MLCI valuation is being assessed using available models.
Valuation anchors are currently not available.
MLCI displays fair financial health with a composite quality score of 50/100, supported by a Piotroski F-Score of 4/9, Return on Invested Capital (ROIC) of -40.0%.
MLCI pays a 6.8% dividend yield, covered by a 0% payout ratio with 1 years of growth, supplemented by a 4.6% buyback yield.
MLCI's current growth trajectory is Stable. The company achieved -106.3% 1Y revenue growth and -3640.0% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Hold based on 0 analysts. The consensus price target represents a N/A change from current levels.
Investment risks for MLCI include: -68.3% 1-year max drawdown. Volatility risk is characterized by a beta of 0.96x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.